BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7703384)

  • 1. Proliferative activity of cyst epithelium in human renal cystic diseases.
    Nadasdy T; Laszik Z; Lajoie G; Blick KE; Wheeler DE; Silva FG
    J Am Soc Nephrol; 1995 Jan; 5(7):1462-8. PubMed ID: 7703384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphology of cystic renal lesions. Lectin and immuno-histochemical study.
    Kovács J; Zilahy M; Gomba S
    Acta Chir Hung; 1997; 36(1-4):176-8. PubMed ID: 9408336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease.
    Ramasubbu K; Gretz N; Bachmann S
    J Am Soc Nephrol; 1998 Jun; 9(6):937-45. PubMed ID: 9621276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study.
    Nadasdy T; Laszik Z; Blick KE; Johnson DL; Silva FG
    Hum Pathol; 1994 Jan; 25(1):22-8. PubMed ID: 7906246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
    Khurana KK; Truong LD; Verani RR
    Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histogenesis of the renal cysts in adult (autosomal dominant) polycystic kidney disease: a histochemical study.
    Verani RR; Silva FG
    Mod Pathol; 1988 Nov; 1(6):457-63. PubMed ID: 3065782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of human polycystic and medullary cystic kidney disease with diphenylamine-induced cystic disease.
    Evan AP; Gardner KD
    Lab Invest; 1976 Jul; 35(1):93-101. PubMed ID: 940325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyst formation and growth in autosomal dominant polycystic kidney disease.
    Grantham JJ; Geiser JL; Evan AP
    Kidney Int; 1987 May; 31(5):1145-52. PubMed ID: 3599654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human acute tubular necrosis: a lectin and immunohistochemical study.
    Nadasdy T; Laszik Z; Blick KE; Johnson DL; Burst-Singer K; Nast C; Cohen AH; Ormos J; Silva FG
    Hum Pathol; 1995 Feb; 26(2):230-9. PubMed ID: 7860054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of epidermal growth factor receptor and proliferative activity of cyst epithelium in human renal cystic diseases.
    Compérat E; Ferlicot S; Camparo P; Eschwege P; Ba N; Benoit G; Bédossa P; Paradis V
    Urol Int; 2006; 76(3):269-73. PubMed ID: 16601392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic disease of the kidney. Evaluation and classification based on nephron segment and cell-type specific markers.
    Holthöfer H; Kumpulainen T; Rapola J
    Lab Invest; 1990 Mar; 62(3):363-9. PubMed ID: 1690315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD.
    Vijayakumar S; Dang S; Marinkovich MP; Lazarova Z; Yoder B; Torres VE; Wallace DP
    Am J Physiol Renal Physiol; 2014 Mar; 306(6):F640-54. PubMed ID: 24370592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant epithelial cell growth in autosomal dominant polycystic kidney disease.
    Wilson PD
    Am J Kidney Dis; 1991 Jun; 17(6):634-7. PubMed ID: 2042637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic gene dosage influences kidney lesions after nephron reduction.
    Le Corre S; Viau A; Burtin M; El-Karoui K; Cnops Y; Terryn S; Debaix H; Bérissi S; Gubler MC; Devuyst O; Terzi F
    Nephron; 2015; 129(1):42-51. PubMed ID: 25531116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic kidney disease: etiology, pathogenesis, and treatment.
    Martinez JR; Grantham JJ
    Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acquired cystic kidney disease and autosomal dominant polycystic kidney disease--precancerous condition?].
    Schmitt MF; Noronha I; Jäger T; Ritz E; Waldherr R
    Verh Dtsch Ges Pathol; 1989; 73():428-35. PubMed ID: 2482633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical studies of the distribution of alpha and pi isoforms of glutathione S-transferase in cystic renal diseases.
    Hiley CG; Otter M; Bell J; Strange RC; Keeling JW
    Pediatr Pathol; 1994; 14(3):497-504. PubMed ID: 8066005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Scenarios in Chronic Kidney Disease: Cystic Renal Diseases.
    Meola M; Samoni S; Petrucci I
    Contrib Nephrol; 2016; 188():120-30. PubMed ID: 27169740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal sodium pump distribution during renal tubulogenesis in congenital murine polycystic kidney disease.
    Avner ED; Sweeney WE; Nelson WJ
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7447-51. PubMed ID: 1323837
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.